Stock Price Quote

HEALTHCARE GLOBAL ENTERPRISES LTD.

NSE : HCGBSE : 539787ISIN CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse : HCG
BSE358.00-1.3 (-0.36 %)
PREV CLOSE ( ) 359.30
OPEN PRICE ( ) 370.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3532
TODAY'S LOW / HIGH ( )353.85 370.30
52 WK LOW / HIGH ( )286 401
NSE358.25-2 (-0.56 %)
PREV CLOSE( ) 360.25
OPEN PRICE ( ) 360.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 358.25 (566)
VOLUME 90869
TODAY'S LOW / HIGH( ) 353.10 363.00
52 WK LOW / HIGH ( )290.1 401
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1998
Management Info
B S Ajai Kumar - Chairman - Managing Director
Registered Office

Address H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama Nagar,
Bengaluru,
Karnataka-560027

Phone 080 - 33669999

Email info@hcgoncology.com

Website www.hcgoncology.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

09Mar HealthCare Global Enterprises informs
HealthCare Global Enterprises informed about the execution of Transfer o..
26Feb HealthCare Global Enterprises submits
Pursuant to the relevant provisions of SEBI (Listing Obligations and Dis..
30Dec HealthCare Global Enterprises informs
HealthCare Global Enterprises has attached copies of newspaper advertise..
18Nov HealthCare Global Enterprises informs
HealthCare Global Enterprises has informed that it enclosed Transcript o..
05Oct Nazara Technologies, Strides Pharma Sc
Nazara Technologies’ material subsidiary -- Nodwin Gaming’s Singapore su..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit83.3401.899999999999
Gross Profit 149.5 576.199999999999
Operating Profit 522.51910.8
Net Sales 2672.110075.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kovai Medical Center (BSE)
peergroup  4625.35 (13.73%)
M.Cap ( in Cr)5061.18
Metropolis Health. (BSE)
peergroup  1904.30 (3.59%)
M.Cap ( in Cr)9755.50
Dr. Lal Pathlabs (BSE)
peergroup  2555.05 (0.76%)
M.Cap ( in Cr)21329.65
Aster DM Healthcare (BSE)
peergroup  359.35 (3.31%)
M.Cap ( in Cr)17950.00
Fortis Healthcare (BSE)
peergroup  462.25 (2.22%)
M.Cap ( in Cr)34897.94

Shareholding Pattern

PROMOTERS 71.28%
MUTUAL FUNDS/UTI 6.49%
NON-INSTITUTION 13.46%
FI/BANKS/INSURANCE 0.14%
GOVERNMENT 0%
FII 0%

About Healthcare Global Enterprises Ltd.

Healthcare Global Enterprises Ltd. was incorporated in the year 1998. Its today's share price is 358. Its current market capitalisation stands at Rs 4986.57 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10055.73 Cr and Total Income of Rs.10275.9 Cr. The company's management includes Rajiv Mailwal, Meghraj Arvindrao Gore, Anjali Rossi Ajaikumar, Pradip Kanakia, Jeyandran Venugopal, Rajagopalan Raghavan, Geeta Mathur, Amit Soni, Siddharth Patel, B S Ajai Kumar, Sunu Manuel.

It is listed on the BSE with a BSE Code of 539787 , NSE with an NSE Symbol of HCG and ISIN of INE075I01017. It's Registered office is at H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama NagarBengaluru-560027, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.